INT-41

N/A

Report date: 2023/10/26 17:02:58

Base Information

Drug NameINT-41
Drug Alias Namerecombinant adeno-associated virus vector containing DNA encoding INT41 intrabodyINT-41
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVybion Inc
China Registration ClassN/A

Develop Information

Active CompaniesVybion Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A